Dr. Jerome Coffey:

Yes. There was an NCI all-Ireland cancer consortium meeting in Queen's University, Belfast, a year or two ago and there was a special session on this. The other countries and jurisdictions doing colorectal cancer screening gave their experience, which was the same, namely, that it was hard to get uptake. Perhaps patients are embarrassed to be tested in that way or whatever. It takes continuous effort to get the rates up to a level at which they have an impact. What is also unique about colorectal screening is that it picks up pre-cancerous lesions. It does not necessarily find much cancer but does find a lot of polyps that would otherwise have developed into cancer over time. That is a much longer-term benefit.